Jun 17, 2026 6:00 am EDT NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes
Jun 15, 2026 5:24 pm EDT NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes
Apr 23, 2026 7:05 am EDT NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration
Apr 13, 2026 7:05 am EDT NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026
Mar 16, 2026 7:05 am EDT NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling
Feb 25, 2026 7:05 am EST NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
